OCR Text |
Show Kenny Foundation Co-Sponsors Live Polio Vaccine Test Minneapolis, Minn. Financed in part by a grant from the Sister Elizabeth Kenny foundation, founda-tion, a test of "tamed" live virus iiifWJ ""in i , 1 ' 1 ' polio vaccine, administered ad-ministered orally in capsule form or in infants' formula, for-mula, is currently being conducted by the state of Minnesota, according ac-cording to Dr. E. J. Huenekens, national na-tional medical director. di-rector. Participants in " . the test, results Dr. Huenekens o which wU, fee evaluated in 1959, include a majority ma-jority of 1,400 residents of University Uni-versity of Minnesota village, near the campus here. Co-sponsor of the project is Lederle Laboratories, Pearl River, N. Y. The Pan-American Sanitary bureau, a branch of the World Health Organization, also is using the oral polio vaccine in tests in Central and South America. A severe polio outbreak in Columbia last spring resulted in a program of oral vaccine administration ad-ministration to both children and adults throughout that stricken South American country. Dr. Mauricio da Silva, formerly for-merly on the Elizabeth Kenny institute staff in Minneapolis and University of Minnesota assistant assist-ant professor of pediatrics, now a special polio consultant with the Pan-American Sanitary bureau, bu-reau, helped plan the Latin American vaccine trials and is medical supervisor of the study. The oral vaccine against each of the three types of polio is given at three-week intervals. It is considered capable of conferring con-ferring long-lasting immunity against polio without booster doses. Grownups take the vaccine in capsule form. For infants and small children, the capsule is opened and the contents stirred into a spoonful of jam or liquid. |